• Zoetis received FDA approval for Convenia RTU for Dogs to treat susceptible bacterial skin infections.
• The single-injection treatment provides up to 14 days of antibiotics, with a more concentrated formulation delivering the same dose in less volume.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610201642BIZWIRE_USPR_____20261020_BW644906) on October 20, 2026, and is solely responsible for the information contained therein.